Minto and Eleveld Remifentanil Target Controlled Infusion (TCI) Models: a Clinical Comparison
Recruiting
Observational Study
Propofol
Anesthesia Brain Monitoring
Remifentanil
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 80
- Sex
- Female
- Study type
- Observational
- Participants needed
- 100 (estimated)
- Sponsor
- University of Padova · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Remifentanil is commonly used as an opioid during general anesthesia. In recent years, several pharmacokinetic/pharmacodynamic (PK/PD) models for target-controlled infusion (TCI) have been developed, with the Eleveld model being one of the most recent and designed for broad applicability.
The aim of this study is to compare the Eleveld TCI model with the routinely used Minto model, in order to ev…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Undergo general anaesthesia with Targeted Controlled Infusion of Propofol (Eleveld model) and Remifentanil (Minto or Eleveld model)
Exclusion Criteria:
* Neurological disease
* Psychiatric disease
Contacts
No contact information available.